Estimation of vaccine efficacy for variants that emerge after the placebo group is vaccinated.
SARS-CoV-2 continues to evolve and the vaccine efficacy against variants is challenging to estimate. It is now common in phase III vaccine trials to provide vaccine to those randomized to placebo once efficacy has been...
Read More